2015-05-30-世界卫生组织-Meningitis_weekly_bulletin_25_-_31_May_2015_12页_1mb
报告摘要
Meningitis Weekly Bulletin Summary (Week 22, 2015)
Region: West Africa; Meningococcal Epidemic Surveillance Network
I. Epidemiological Situation (Week 22)
- Active Cases: 226 suspected meningitis cases reported, with 20 deaths (case fatality rate: ~8.8%).
- Affected Countries: Benin, Burkina Faso, Cameroon, Guinea, Mali, Niger, Nigeria, Sudan, Chad, Togo.
- Vaccination Status: Burkina Faso, Mali, Niger, Sudan, Chad, Togo are fully vaccinated (marked T) with MenAfriVac. Benin, Cameroon, Mauritania are partially vaccinated (marked P).
- Democratic Republic of Congo (DRC): No applicable epidemic thresholds due to territory primarily outside the African meningitis belt (~142 cases; 12 deaths).
- Alert/Epidemic Districts: No districts in Alert or Epidemic phase reported in countries that notified cases this week.
- Completeness: Varies significantly by country (e.g., 11.3%, 17.6%, 63.1%).
II. Synthesis of Epidemiological Situation (Weeks 01-22)
- Total Cases: 17,462 suspected meningitis cases reported over 22 weeks.
- Total Deaths: 1,296 deaths (case fatality rate: ~7.4%).
- Lethality & Alert/Epidemic: High lethality in Centrafrique (14.5%), Guinea (8.2%), Chad (17.8%). Active alerts/epidemics reported in Nigeria, Niger, Sudan, Chad (district percentages indicate weeks having alerts/epidemics).
- Completeness: Average ~63.1% of weeks reported for the period.
III. Laboratory Data Synthesis (Weeks 01-22)
- CSF Samples: 3,121 CSF samples collected from 17,462 suspected cases (approx. 17.9%).
- Pathogens Identified (among tested samples):
- Neisseria meningitidis: Dominant, Serogroup W135 highly prevalent.
- Serogroups: NmA (Benin, Burkina Faso, Niger, Togo), NmX (many), NmC (many), NmB (many).
- Hib, S. pneumoniae, other pathogens also detected.
- Detection Limitations: No specific data on the Tougan (Burkina Faso) case.
IV. Key Notes
- WHO monitors meningitis cases in the West Africa region, primarily Neisseria meningitidis serogroups prevalent in the meningitis belt.
- Data presented are provisional, derived from notifications, and subject to change upon finalization.
- Laboratory confirmation using methods like PCR and culture is part of surveillance efforts.
展开完整摘要
试读结束,高清完整版pdf/doc/ppt,请点下载